BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 26596013)

  • 1. Efficacy of high dose systemic versus combined (systemic and intratympanic) corticosteroid therapy in idiopathic sudden sensorineural hearing loss: A prospective randomized trial and risk factor analysis.
    Kovács M; Uzsaly J; Bodzai G; Pap I; Lippai B; Dergez T; Németh A; Gerlinger I; Szanyi I; Bakó P
    Am J Otolaryngol; 2024; 45(1):104099. PubMed ID: 37948820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible errors in the article "Potential benefits of salvage intratympanic dexamethasone injection in profound idiopathic sudden sensorineural hearing loss".
    Shan X; Wang E
    Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4641. PubMed ID: 32844304
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of intratympanic glucocorticoid treatment in sudden hearing loss].
    Hoch S; Kremper L; Rudhart SA; Stuck BA
    HNO; 2024 Apr; 72(4):291-302. PubMed ID: 38351342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early treatment for benign paroxysmal positional vertigo secondary to sudden sensorineural hearing loss.
    Li GF; Liu M; Zhang YZ; Wang YT; Su L; Liu RR
    Medicine (Baltimore); 2023 Oct; 102(40):e35480. PubMed ID: 37800834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperbaric Oxygen Therapy Versus Intratympanic Steroid for Salvage Treatment of Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis.
    Lei X; Feng Y; Xia L; Sun C
    Otol Neurotol; 2021 Sep; 42(8):e980-e986. PubMed ID: 34172651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of side effects of different steroids used in intratympanic injections.
    Wang Y; Zhao J; Wu J; Ren T; Wu Y
    Am J Otolaryngol; 2024; 45(3):104258. PubMed ID: 38513512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic Dexamethasone in Sudden Sensorineural Hearing Loss.
    Kanotra S; Kumar A; Langar B; Kalsotra P; Paul J
    Indian J Otolaryngol Head Neck Surg; 2022 Dec; 74(Suppl 3):3947-3956. PubMed ID: 36742583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral Sudden Sensorineural Hearing Loss and Intralabyrinthine Hemorrhage in a Patient With COVID-19.
    Chern A; Famuyide AO; Moonis G; Lalwani AK
    Otol Neurotol; 2021 Jan; 42(1):e10-e14. PubMed ID: 33301283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Batroxobin Versus the Combination of Batroxobin and Intratympanic Dexamethasone Injection in the Treatment of Sudden Sensorineural Hearing Loss.
    Jia Q; Zhu J; Wu D; Chen T; Hong C
    Ear Nose Throat J; 2024 Jan; ():1455613231222381. PubMed ID: 38282309
    [No Abstract]   [Full Text] [Related]  

  • 10. Intratympanic Triamcinolone or Dexamethasone in Sudden Sensory Neural Hearing Loss: A Randomized Clinical Trial.
    Emami H; Tajdini A; Amirzargar B; Habibi S; Varpaei HA; Gholami R; Karimi A; Jazini Zadeh S; Mehrban AH
    Indian J Otolaryngol Head Neck Surg; 2023 Dec; 75(4):3545-3552. PubMed ID: 37974838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observation on the effect of tympanic injection of methylprednisolone in the treatment of refractory sudden deafness.
    Wang W; Xiao X
    Minerva Surg; 2024 Aug; 79(4):492-494. PubMed ID: 34790939
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical efficacy and value of hyperbaric oxygen combined with dexamethasone in the treatment of sudden deafness.
    Chen Y; Mei X
    Minerva Surg; 2024 Aug; 79(4):485-486. PubMed ID: 34714032
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical Efficacy of Retroauricular Injection of Methylprednisolone Sodium Succinate in the Treatment of Sudden Deafness with Type 2 Diabetes.
    Zhong Z; Wang X; Xu K; Tao J
    Comput Math Methods Med; 2022; 2022():3097436. PubMed ID: 35912152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Tinnitus with Intratympanic Injection of Dexamethasone Versus Oral Drugs.
    Mohanty A; Mukherjee M; Das SK; Sikder B
    Indian J Otolaryngol Head Neck Surg; 2023 Sep; 75(3):2029-2034. PubMed ID: 37636606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosafety and potency of high-molecular-weight hyaluronic acid with intratympanic dexamethasone delivery for acute hearing loss.
    Hwang YJ; Oh SH; Lee JH; Park MK; Suh MW
    Front Pharmacol; 2024; 15():1294657. PubMed ID: 38292943
    [No Abstract]   [Full Text] [Related]  

  • 16. Intratympanic injection of hydrogel nanodrug for the prevention and treatment of sensorineural hearing loss.
    Zhai T; Ai P; Tang Z; He C; Chen X; Yang S; Wu N
    J Otol; 2023 Oct; 18(4):235-239. PubMed ID: 37877070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Efficacy of Mesotympanum Injection and Posterior Auricular Injection in Sudden Hearing Loss of Diabetes Patients.
    International BR
    Biomed Res Int; 2024; 2024():9818316. PubMed ID: 38230045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of intratympanic dexamethasone injection for the moderate and severe sudden deafness with BPPV].
    Zhou X; Yu Y; Zhao Y; Wang Y; Liu Z; Liu Q
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 May; 29(10):934-6. PubMed ID: 26596013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of intratympanic Dexamethasone injection for sudden deafness at different time intervals].
    Yang PL; Zhang ZP
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(11):822-824. PubMed ID: 29774994
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.